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Abstract.
Background: Although required to improve the usability of cognitive screening instruments (CSIs), the use of cut-off scores
is controversial yet poorly researched.
Objective: To explore cut-off scores for two short CSIs: the Standardized Mini-Mental State Examination (SMMSE) and
Quick Mild Cognitive Impairment (Qmci) screen, describing adjustments in scores for diagnosis (MCI or dementia), age (≤,
>75 years), and education (<, ≥12 years), comparing two methods: the maximal accuracy approach, derived from receiver
operating characteristic curves, and Youden’s Index.
Methods: Pooled analysis of assessments from patients attending memory clinics in Canada between 1999–2010 : 766 with
mild cognitive impairment (MCI) and 1,746 with dementia, and 875 normal controls.
Results: The Qmci was more accurate than the SMMSE in differentiating controls from MCI or cognitive impairment (MCI
and dementia). Employing the maximal accuracy approach, the optimal SMMSE cut-off for cognitive impairment was <28/30
(AUC 0.86, sensitivity 74%, specificity 88%) versus <63/100 for the Qmci (AUC 0.93, sensitivity 85%, specificity 85%).
Using Youden’s Index, the optimal SMMSE cut-off remained <28/30 but fell slightly to <62/100 for the Qmci (sensitivity
83%, specificity 87%). The optimal cut-off for MCI was <29/30 for the SMMSE and <67/100 for the Qmci, irrespective of
technique. The maximal accuracy approach generally produced higher Qmci cut-offs than Youden’s Index, both requiring
adjustment for age and education. There were no clinically meaningful differences in SMMSE cut-off scores by age and
education or method employed.
Conclusion: Caution should be exercised selecting cut-offs as these differ by age, education, and method of derivation, with
the extent of adjustment varying between CSIs.
Keywords: Cognitive screening, cut-offs, dementia, mild cognitive impairment, Quick Mild Cognitive Impairment screen,
Standardized Mini-Mental State Examination
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INTRODUCTION
While screening for cognitive impairment is advo-
cated by some [1–3], there remains limited evidence
supporting routine cognitive screening in clinical
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practice [4, 5]. This is in part because most cognitive
screening instruments (CSI) lack sufficient sensitiv-
ity and specificity to differentiate normal cognition
from mild cognitive impairment (MCI) and dementia
[2, 4, 6], but also because of the effects of age and
education on scoring variability [7, 8]. Misclassify-
ing may be harmful, as treatments indicated at one
stage may not beneficial at another [9–11].
The utility of screening instruments is defined by
two conditional probabilities, sensitivity and speci-
ficity, that rule in (sensitivity) or rule out (specificity)
disease [12]. In general, sensitivity and specificity
are inversely related and vary with the threshold
[13]. Ideally, screening tests should strike a balance
between both, so they can confirm or exclude a dis-
ease, although sensitivity is particularly important for
short screens to reduce the rate of false negatives. Cut-
off scores, transition points along the spectrum of
cognitive impairment, may be useful in busy clinical
practice although their utility is limited by context and
uncertainty regarding the optimal method of estab-
lishing test cut points [14]. Two of the most widely
used methods are the maximal accuracy [15] and
Youden’s Index [16] approaches. The latter often pro-
vides higher cut-offs and greater sensitivity, and has
been suggested as the optimal method for develop-
ing cut-offs for short CSIs [15]. Although age and
educational cut-offs, based upon population-based
norms, are available for some CSIs including the
Mini-Mental State Examination (MMSE) [7] and
the Montreal Cognitive Assessment (MoCA) [17,
18], few studies have published usable cut-off scores
for patients presenting with symptomatic memory
loss [19].
The objectives of this study are to (1) examine
and compare the effects of using different meth-
ods of defining cut-off scores on two short CSIs,
the widely used MMSE (Standardized MMSE), and
a short screen for MCI and early dementia called
the Quick Mild Cognitive Impairment (Qmci) screen
[20]; (2) to investigate the extent that these cut-off
scores require adjustment for age and education; and
(3) develop cut-off scores for the Qmci screen.
MATERIALS AND METHODS
Participants and data collation
Data from three sources: the Geriatric Assess-
ment Tool (GAT) [21] and original Qmci validation
databases [20], and the DARAD (Doxycycline
And Rifampicin for Alzheimer’s Disease) [22]
clinical trial database were analyzed. Participant
characteristics and recruitment from all three stud-
ies have been published previously [20–22] and are
presented in Fig. 1 and Table 1 below. In summary,
the GAT database was collected in outpatient geriatric
clinics in two university hospitals in Ontario, Canada
between 1999 and 2010. The GAT is a geriatric
outpatient database including patients aged 41–104
years [21]. The Qmci validation database includes
patients referred for assessment of cognition, aged
≥55 years, recruited from four outpatient memory
clinics in Ontario, Canada [20]. The DARAD was
a multi-center, blinded randomized controlled trial
conducted between 2006 and 2010, comparing the
effect of rifampicin and doxycycline to placebo on
the progression of Alzheimer’s disease (AD) [22].
The DARAD database includes patients aged ≥50
years with mild to moderate AD recruited from 14
Canadian geriatric outpatient clinics.
All data were collected under the supervision of
the same principle investigator (WM) in a manner
consistent with the Helsinki Declaration of 1975 and
were approved by the local research ethics committee
at the time. No additional approval was required for
this secondary analysis. Each participant underwent
similar comprehensive work-up including laboratory
investigations, neuropsychological assessment, and
neuroimaging where appropriate [20–22]. Dementia
was diagnosed using the Diagnostic and Statisti-
cal Manual of Mental Disorders (4th-edition) [23].
MCI was diagnosed using Petersen’s Criteria [24]
in patients presenting with subjective and objec-
tive memory loss without loss of function. Those
with active depression, screened using the Geriatric
Depression Scale [25], were excluded. All partici-
pants were English literate. Persons attending clinic
with patients, mainly caregivers (Qmci database,
n = 630), and patients without memory loss attending
geriatric clinics (GAT database, n = 245), recruited by
convenience sampling, were available as normal con-
trols. No controls were available from the DARAD
database.
Participants were included in this analysis if paired
SMMSE and Qmci scores were available. To ensure
a consistent cross sectional approach and to reduce
heterogeneity between the different samples, only
patients with AD, vascular dementia (VaD), or mixed
AD-VaD were included. This is consistent with the
original validation of the Qmci screen [20] and
recruitment for the DARAD trial [22]. Patients with
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Fig. 1. Flow chart presenting the selection of participants from three data sets: The Geriatric Assessment Tool (GAT), Quick Mild Cognitive
Impairment (Qmci) screen, and Doxycycline and Rifampicin for Alzheimer’s Disease (DARAD) trial databases including the number of
normal controls, patients with mild cognitive impairment (MCI) and dementia.
missing demographic data (age or education) were
also excluded. In total, 4,565 subjects were avail-
able. Of these, 3,387 were included. The majority
(n = 1,081) were excluded from the GAT database: 46
with Lewy body dementia, 15 with Parkinson’s dis-
ease dementia, 33 with frontotemporal dementia, 70
with other dementia subtypes (post-traumatic, anes-
thetic, alcohol, or other mixed non AD-VaD), and
571 with depression (195 with isolated depression, 94
with concomitant MCI, and the remainder with active
co-morbid depression and established dementia). For
346 subjects, the diagnosis was unclear. A further
97 were excluded from the Qmci and DARAD data
sets due to missing data. Selection for this analysis is
presented as a flow chart in Fig. 1.
Measures
The SMMSE and Qmci were available in all
three databases. The SMMSE is a standardized
version of the MMSE, scored out of 30 points,
which improved inter-rater reliability by the inclu-
sion of explicit administration and scoring guidelines
[26, 27]. The Qmci screen is a short (median time
4.24 minutes) [28], valid, and reliable CSI with
six subtests, covering five cognitive domains: ori-
entation, working memory, sematic memory (verbal
fluency for animals), visuospatial/executive function
(clock drawing) and two tests of episodic memory
(delayed recall and logical memory, the immedi-
ate verbal recall of a short story) [28]. Originally
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validated in English, it has now been validated in
Dutch [29] and Turkish [30]. It is scored from 0 (indi-
cating severe cognitive impairment) to 100 points
(normal cognition). It has comparable accuracy to
the MoCA [31, 32] and similar responsiveness to
the standardized Alzheimer‘s Disease Assessment
Scale-cognitive section, Clinical Dementia Rating
scale, and Lawton-Brody Activities of Daily Liv-
ing scale in clinical trials [33]. Alternative, validated
forms of the Qmci subtests were used to minimise
learning effects [34].
Analysis
Pooled data were grouped according to age (≤75
or >75 years) and education (<12 or ≥12 years), to
create four subgroups. An age cut-off of 75 years pro-
vided the best balance in numbers between the four
subgroups and represents the accepted age cut-off for
cognitive impairment using the MMSE [35], above
which it is suggested that scores must be adjusted
to account for age. The cut-off for education was 12
years, the average length of formal schooling in North
America [36].
Optimal cut-off scores were estimated using two
methods: Youden’s Index [16] and maximal accu-
racy calculated from receiver operating characteristic
(ROC) curves. The cut-point derived by Youden’s
Index optimizes a tests ability to differentiate when
equal weight is given to sensitivity and specificity. It
is defined mathematically as: J = Sensitivity + Speci-
ficity – 1 [16]. Diagnostic accuracy was calculated
from the area under the curve (AUC) of ROC curves
with scores >0.8 regarded as good and >0.9 as excel-
lent. Sensitivity, specificity, positive predictive value
(PPV), and negative predictive value (NPV) were cal-
culated for candidate cut-off points. The maximal
accuracy method is based on maximizing the overall
classification accuracy (OCA) such that OCA = true
positives + true negatives. Likelihood ratios for the
probability of having cognitive impairment (MCI and
dementia) were also determined. A Positive Likeli-
hood Ratio (PLR) of between 2–5 suggests a small
chance, 5–10 moderate, and >10 a large chance of
having cognitive impairment. A Negative Likelihood
Ratio (NLR) of 0.2–0.5 suggests a small chance,
0.1–0.2 moderate, and <0.1 a large chance of not
having the condition. The Mann–Whitney U test
compared non-parametric data and student’s t-tests
compared parametric data. The Kruskal-Wallis H test
was used for comparisons between three or more
non-normally distributed groups. ROC curves were
compared using the Hanley method [37]. Binary
logistic regression was used to adjust ROC curve
analysis for the effects of age and education.
RESULTS
Characteristics
In all, 3,387-paired assessments from 2,074 indi-
viduals were included. The median age of all
participants at assessment was 75 years, interquartile
range (IQR) ±13.5. The median years in education
were 12 (±5) and 46.9% were male. The median
age of those with dementia was 78 (±8) years,
older than normal controls 70 (±14) (p < 0.001)
and those with MCI, 76 (±10) (p < 0.001). The
median number of years in education was 12 (±5)
for those with dementia compared with 13 (±4)
(p < 0.001) for controls and 12 (±4) (p = 0.46) for
MCI. The characteristics of those included in each
database and comparisons between databases are
presented in Table 1. The characteristics of partic-
ipants according to their age and educational level
are presented in Supplementary Table 1. In sum-
mary, the median SMMSE score for controls was
29/30 (±2) points, compared to 28/30 (±3) for MCI
and 23/30 (±8) for dementia. SMMSE scores were
significantly different between these three diagnostic
groups, χ2 (2) = 1,262 (p < 0.001). The median Qmci
scores were 74/100 (±15) points for controls, 57/100
(±20) for MCI, and 37/100 (±26) for dementia. Qmci
scores were also significantly different in the three
groups, χ2 (2) = 1,379 (p < 0.001). Median age, gen-
der, education, SMMSE, and Qmci screen scores,
though similar, were significantly different between
the three databases; participants in the dementia trial
database (DARAD) were, as would be expected by
the results above, older, had spent less time in formal
education and had lower median SMMSE and Qmci
scores.
Effects of age and education on median cognitive
screen scores
Median SMMSE scores were significantly higher
for normal controls than for patients with MCI, irre-
spective of age or education, though clinically the
results appeared similar, particularly for older par-
ticipants (>75) with less time in education (<12)
both with a median SMMSE score of 28/30, reflect-
ing the known ceiling effects of the instrument.
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Differences between median Qmci scores for controls
and those with MCI were all statistically significantly
different, irrespective of age and education but the
differences were more clinically meaningful (mini-
mum difference >10 points), for example the median
Qmci screen score for younger patients (≤75) with
more education (≥12) was 78/100 and 59/100 for
normal controls and MCI respectively, a median 19-
point difference. Median SMMSE and Qmci screen
scores for patients with established dementia were
the lowest for younger patients with less educa-
tion. These results are presented in Supplementary
Table 1.
Cut-off scores using the maximal accuracy
method
Both instruments had good to excellent accuracy
in differentiating patients with cognitive impairment
(MCI or dementia) from controls. Scores for both
instruments were highest for younger (≤75), more
educated (>12) participants. The Qmci was, how-
ever, significantly more accurate than the SMMSE
in identifying cognitive impairment, with an AUC
score of >0.90, irrespective of participant age or
education (p < 0.001). Its superior accuracy was par-
ticularly evident in younger (≤75) and more educated
(>12) patients (AUC of 0.84 for the SMMSE ver-
sus 0.92 for the Qmci, p < 0.001). As expected the
Qmci was also statistically significantly more accu-
rate than the SMMSE in detecting MCI, irrespective
of age or education, while there was no difference
for differentiating dementia from MCI. The optimal
SMMSE cut-off for cognitive impairment, using the
maximal accuracy approach was <28/30 (AUC 0.86),
which produced a sensitivity of 74% and specificity
of 88%. The optimal Qmci cut-off was <63/100 (AUC
0.93), which produced a sensitivity of 85% and speci-
ficity of 85%. Comparisons between AUC scores and
the cut-off scores generated using the maximal accu-
racy method, for both instruments and according to
their age and education, are presented in Table 2. The
sensitivity and specificity obtained at different cut-
off points including that found using the maximal
accuracy approach are presented in Supplementary
Table 2.
Cut-off scores using Youden’s Index
Using Youden’s Index, the optimal cut-off score
for the SMMSE for cognitive impairment (MCI or
dementia) was <28/30. This provided a sensitivity
of 74% and a specificity 88%. The optimal cut-off
for the Qmci was <62/100, producing a sensitivity of
83% and specificity of 87% for cognitive impairment.
Examining age and education specific cut-offs again
showed that scores for both instruments were high-
est for younger (≤75), more educated (>12) subjects.
The Qmci was more sensitive (83%) and specific
(73%) for MCI than the SMMSE (59% and 72%,
respectively). Cut-offs for the Qmci screen calculated
using Youden’s Index are presented in Fig. 2. Detailed
tables comparing the sensitivity and specificity of
both CSIs, for a range of cut-off scores, calculated
from Youden’s Index are provided in Supplementary
Table 3.
Overall, SMMSE cut-offs were similar whether
using Youden’s Index or the maximal accuracy
approach, while Qmci cut-offs varied depending upon
the method used and by the age and education
defined subgroups. These comparisons are presented
in Table 3.
Likelihood ratios
Likelihood ratios were calculated for several
cut-off scores, for both instruments, for the total
population and by age and education. The optimal
SMMSE cut-off for cognitive impairment (<28/30),
calculated using Youden’s Index, provided a moder-
ate chance of cognitive impairment (PLR 5.97) and
a small chance of normal cognition (NLR 0.29). The
cut-off using the maximal accuracy method was the
same. Likelihood ratios also confirmed the choice of
cut-off scores for each subgroup according to age and
education. For example, using Youden’s Index or the
maximal accuracy approach, the cut-off for older par-
ticipants (>75) with less education (<12) (i.e.,<27/30)
had a moderate chance of cognitive impairment (PLR
5.25) and a small chance of being classified as normal
(NLR 0.29).
At the optimal Qmci cut-off for cognitive impair-
ment, calculated using Youden’s Index (<62/100),
participants also had a moderate chance of having
cognitive impairment (PLR 6.22) and a small chance
of having normal cognition (NLR 0.20). At <63/100
points, the cut-off calculated by the maximal accu-
racy approach, there was also a moderate chance of
having CI (PLR 5.65) but a moderate chance of being
normal (NLR 0.18). Complete results for likelihood
ratios according to diagnostic classification (normal
cognition, MCI or dementia) and age (≤75 or >75
years) and education (<12 or≥12 years) are presented
in the Supplementary Table 4.
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Fig. 2. Age and educational cut-off scores separating normal
controls (NC) from (A) cognitive impairment (mild cognitive
impairment and dementia) and (B) mild cognitive impairment
from NC for the Quick Mild Cognitive Impairment (Qmci) screen
calculated using Youden’s Index.
DISCUSSION
This paper presents cut-off scores for two short
CSIs, the SMMSE and Qmci screen, adjusted for
age and education, based upon a large population
of participants including patients with symptomatic
memory loss, in three pooled databases, using two
derivation methods. While data on cut-off scores have
been partially presented for the MoCA [19], to our
knowledge, this is the first study to investigate in
depth the differential effects of age and education on
cut-off scores, comparing two short CSIs in partic-
ipants with symptomatic cognitive impairment, one
designed specifically to screen for MCI (Qmci). It
is also one of only a few studies to investigate the
effects of different methods of calculating cut-offs
[15], despite the regularity that they are used in clin-
ical practice.
The results show small, albeit significant, differ-
ences in median SMMSE, and large and significant
differences in median Qmci scores, which clearly sep-
arate normal controls, MCI, and dementia. This study
found that cut-off scores are influenced by several
factors including their derivation method as well as
age, education and diagnostic classification, and that
these effects also vary between instruments. Com-
paring cut-off scores calculated with Youden’s Index
and the maximal accuracy method showed that the
Table 3
Comparison of cut-off scores for the Standardized Mini-Mental State Examination (SMMSE) and Quick Mild Cognitive Impairment (Qmci)
screen, using Youden’s Index and the maximal accuracy methods calculated from the area under the curve (AUC) grouped by age (≤75,
>75 years) and education (<12,≥ 12 years), comparing normal controls (NC) to those with cognitive impairment (CI), those with dementia
compared to the rest, those with NC versus mild cognitive impairment (MCI) and those with MCI versus dementia
Subgroup (years) Diagnosis SMMSE Cut-off SMMSE Cut-off Qmci Cut-off Qmci Cut-off
Youden’s Index based on AUC Youden’s Index based on AUC
Overall (n = 3,387) CI versus NC <28 <28 <62 <63
MCI versus NC <29 <29 <67 <67
MCI versus Dementia >25 >25 >45 >45
Dementia versus everything else <27 <27 <54 <54
Age ≤ 75 Edu < 12 (n = 502) CI versus NC <27 <28 <55 <59
MCI versus NC <28 <29 <65 <65
MCI versus Dementia >23 >25 >44 >44
Dementia versus everything else <26 <26 <55 <55
Age ≤ 75 Edu ≥ 12 (n = 1,009) CI versus NC <28 <29 <60 <67
MCI versus NC <29 <29 <69 <69
MCI versus Dementia >26 >26 >49 >47
Dementia versus everything else <28 <28 <60 <58
Age > 75 Edu < 12 (n = 784) CI versus NC <27 <27 <54 <57
MCI versus NC <27 <29 <64 <64
MCI versus Dementia >25 >25 >45 >45
Dementia versus everything else <26 <26 <50 <50
Age > 75 Edu ≥ 12 (n = 849) CI versus NC <28 <28 <56 <58
MCI versus NC <27 <29 <70 <64
MCI versus Dementia >26 >26 >45 >48
Dementia versus everything else <27 <27 <51 <51
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overall scores for the SMMSE and Qmci were similar
irrespective of diagnostic classification. For exam-
ple, the optimal cut-offs for cognitive impairment
(i.e., either MCI or dementia) were <28/30 for the
SMMSE and <62/100 for the Qmci using Youden’s
Index compared with <28/30 and <63/100, respec-
tively, using the maximal accuracy approach, more
or less unchanged. Likelihood ratios, however, sug-
gested that the cut-off scores created using Youden’s
Index were better able, albeit marginally, to classify
patients with confidence.
The study also showed that age and education
affect the cut-off scores for all diagnostic categories
with differences evident between scores depending
on the cut-off method used. This was more obvi-
ous for the Qmci. For example, the optimal SMMSE
cut-off score for detecting cognitive impairment was
<28/30 for young participants (≤75) with more
education (≥12) using Youden’s Index and <29/30
using maximal accuracy, versus <60/100 and <67/100
respectively for the Qmci screen. This suggests that it
requires greater correction for age and education than
the SMMSE, which appeared to be less influenced by
age and education than the Qmci screen.
The effects of age and education on patients pre-
senting with symptomatic memory complaints are
complex. The median scores of the total sample were
lowest for older patients with less education and high-
est for younger patients with the most education.
Median scores for patients with established dementia
were, however, lowest for younger patients with less
education, possibly reflecting more severe pathology
in young patients, without the protective effects of
education. The influence of education on cognition
remains unclear [38] with some but not all studies
suggesting that lower levels of education are associ-
ated with an elevated risk for dementia [38]. Recent
longitudinal data suggests education may delay onset
but does not affect the rate of decline in those with
established dementia [39]. Likewise, education does
not clearly affect decline in cognitive scores for per-
sons without dementia [40].
Comparing the diagnostic accuracy of both CSIs
showed again that the Qmci was significantly more
accurate in differentiating MCI from normal cogni-
tion [20, 31, 32], while both instruments had similar
accuracy for distinguishing dementia. This reflects
that the MMSE and its standardized version are
poorly sensitive to early cognitive changes, particu-
larly in patients with MCI [42]. Likewise, irrespective
of age, education, or method of derivation, all but one
of the SMMSE cut-offs (differentiating MCI from
dementia in young patients with lower levels of edu-
cation) were above the often-used cut-off of <24/30
[27]. The cut-off for older patients with high levels
of education found in this study (<26/30) is, how-
ever, similar to that found in corresponding samples
in North America [43]. For patients with MCI, the
cut-off ranged between <29/30 and <30/30 suggest-
ing that any failure to fully complete the test should
prompt more detailed assessment.
Thus, the SMMSE, while less accurate, requires
less adjustment for age, education, and derivation
method than the more accurate Qmci screen, which
is an advantage. However, it could be argued that
the narrow range of SMMSE cut-off scores, clus-
tered together, limits their utility in clinical practice,
confirming the ceiling effects characteristic of this
instrument [7, 20, 41]. The argument is therefore
that clinicians should have a suite of short CSIs
available (i.e., be trained to score) and make their
selection of which to use based on the diagnostic
pre-test probability, with MCI specific screens used
where MCI is suspected. Given that MoCA cut-offs
for symptomatic cognitive impairment also require
adjustment for age and education [19], suggests that
there may be a trade-off between diagnostic accuracy
and a requirement to adjust cognitive screen scores
for all these factors. Being aware of this is particu-
larly important in order to avoid misclassification in
busy clinical practice.
Strengths and weaknesses
Strengths of this study include the inclusion of
a large sample of patients presenting with mem-
ory loss in a clinic setting, allowing analysis of
subgroups according to age and education. Another
strength is that cut-offs were confirmed as being clin-
ically meaningful using likelihood ratios. The study
includes patients with different dementia subtypes
all of whom underwent a comprehensive assessment
using standardized diagnostic criteria across multi-
ple sites. This paper has a number of limitations. This
study included pooled data from three sources, a clin-
ical trial and two outpatient databases, potentially
resulting in spectrum bias. Baseline characteristics
were significantly different between the three data
sets, although the same principle investigator, using
similar approaches, supervised participant assess-
ment. The findings are drawn from a single country,
potentially reducing the generalizability of results.
However, Canada is ethnically diverse with similar
demographics to many other industrialized nations
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and data were drawn from multiple clinics spread
over a large geographic area. The age and educational
level cut-offs chosen could also limit the external
validity of these results. Although 12 years is the
average number of years of education for older adults
in North America, this figure is lower in other coun-
tries. Another potential limitation is that the efficiency
of the maximal accuracy method, used to develop
cut-offs, varies with disease prevalence.
In summary, this study provides usable cut-off
scores for the SMMSE and Qmci and illustrates the
effects of age and education on cut-off scores for
patients presenting with symptomatic memory loss.
The results suggest that the type of test selected also
determines the extent to which adjustments in age and
education are required. The SMMSE is less accurate
than the Qmci but may also be less affected by age and
education. The results also suggest that cut-offs are
influenced by the method of derivation, which varies
by age, education, and between instruments. Based
upon this analysis, the authors recommend the use
of cut-offs derived by Youden’s Index (presented in
Fig. 1): an overall SMMSE cut-off score of <28/30
for cognitive impairment (MCI and dementia) and
a Qmci cut-off of <62/100. However, although cut-
offs are useful in clinical practice, age and education
impact upon these and while providing a valuable
guide, they should not replace clinical judgment [44].
Further study is required to confirm these findings in
different cultural groups and with different cognitive
tests.
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